Panelists analyzed the concept of penalizing providers who deviate from pathway programs.
Panelists analyzed the concept of penalizing providers who deviate from pathway programs.
Dr Malin said rather than having a penalty, WellPoint chooses to incentivize behavior. When providers select treatments that are “off pathway,” they are reimbursed, but there are additional financial incentives for providers who select treatments that are “on pathway.”
Dr Yu agreed that incentives to change are preferable to penalties. He added that payers should not seek to penalize either— incentives should be determined internally from institutions or at the provider-group level.
Dr Nabhan said that by not achieving a certain pathway metric, a provider technically “penalizes” him or herself by missing the potential financial incentives that are available to them.
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
June 23rd 2025In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Ken Cohen, MD, executive director of translational research at Optum Health.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen